Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
CV 205 – 502 , a new long-acting nonergot dopamine agonist , was given to 15 patients (6 women and 9 men) with PRL-secreting pituitary macroadenomas. The compound was administered in a single daily dose ...
of CAB in patients with prolactinoma proven to be resistant to bromocriptine (BRC) and quinagolide ( CV 205 – 502 ).Twenty-seven patients (19 macro- and 8 microprolactinomas) were treated with CAB at a weekly ...
in the evaluation of GH-deficient states. To assess the effects on GH secretion of a new potent D2- dopamine agonist , the octahydrobenzo(g)quinoline CV205– 502 ( CV ) we have investigated the GH responses in healthy male ...
, Grossman AB. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist , quinagolide, in the treatment of hyper-prolactinemia: a double-blind study . Acta ...
M , et al. 1990 Effects of a new prolactin inhibitor, CV 205 – 502 , in the treatment of human macroprolactinomas. J Clin Endocrinol Metab . 71 : 354 – 359 . Google Scholar Crossref Search ADS PubMed ...
increase in the risk of complications; greater risks are associated with urgency and significant CV , pulmonary, and renal disease. 2.4. Purpose As many years have passed and new evidence has become available ...
) makes the diagnosis more likely. c For the diagnosis of HFpEF, the greater the number of abnormalities present, the higher the likelihood of HFpEF. Open in new tab Patients with non- CV disease, e.g ...
Finzi G.C. Lombroso Finzi III Department of Obstetrics and Gynaecology, University of Milano , Milan, Italy 374. CV 205 - 502 . 24 month's treatment with a new long-acting dopamine agonist in women ...
attention and enhances activity via an indirect effect on dopamine .118–120 However, there is evidence that caffeine can negatively affect blood flow and oxygen supply in the brain through vasoconstriction.121 ...
model may improve the relative IDI for cumulative end-point by 11.4% and 10.5% respectively. These data are very promising, and they are required new investigation with higher statistical power ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!